Mr. Waxman (for himself, Mr. Brown of Ohio, Mr. Dingell, Mr. Deutsch, Mr. Pallone, Mr. Green of Texas, Mr. Stupak, and Mr. Barrett of Wisconsin) introduced the following bill; which was referred to the Committee on Energy and Commerce
To amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act with respect to pediatric studies of drugs, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Best Pharmaceuticals for Children Act. H.R. 3047. 107th
Cong., 1st
sess., Introduced in House October 4, 2001. https://www.govinfo.gov/app/details/BILLS-107hr3047ih.
APA
Congress, House of Representatives (2001, October 4). Best Pharmaceuticals for Children Act (H.R. 3047 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-107hr3047ih.
MLA
United States, Congress, House of Representatives. Best Pharmaceuticals for Children Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-107hr3047ih. 107th Congress, H.R. 3047, Introduced in House 4 Oct. 2001.
Bluebook
H.R.3047 - 107th Congress (2001-2002): Best Pharmaceuticals for Children Act, H.R.3047, 107th Cong. (2001), https://www.govinfo.gov/app/details/BILLS-107hr3047ih.
